Literature DB >> 35821488

Longitudinal Tracing of Lyssavirus Infection in Mice via In Vivo Bioluminescence Imaging.

Kate E Mastraccio1,2, Celeste Huaman1, Eric D Laing1, Christopher C Broder1, Brian C Schaefer3.   

Abstract

Bioluminescence imaging (BLI) is a technique that can be employed to quantify biological processes in living cells. When used in small animal models such as mice, BLI can provide both longitudinal and positional information regarding the biological process under investigation. Although perhaps best known for its utility in non-invasively quantifying tumor burden over time in experimental animals, BLI has also been applied in many pathogenesis models to track pathogen burden and responses to therapeutic interventions. In this chapter, we present a BLI-based method for tracing anatomical progression of lyssavirus infection in a mouse model. We also include validation methods to ensure that semiquantitative BLI data correlate well with viral load. Due to the longitudinal nature of this approach, lyssavirus pathogenesis and therapeutic intervention studies can be performed with far fewer animals than more traditional approaches, which typically require euthanasia of large animal groups at every data collection time point.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Australian bat lyssavirus (ABLV); Bioluminescence imaging (BLI); In vivo imaging; Longitudinal studies; Luciferase; Lyssavirus; Mice; Rabies

Mesh:

Year:  2022        PMID: 35821488     DOI: 10.1007/978-1-0716-2453-1_30

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  34 in total

Review 1.  Overview of bioluminescence tomography--a new molecular imaging modality.

Authors:  Ge Wang; Wenxiang Cong; Haiou Shen; Xin Qian; Michael Henry; Yue Wang
Journal:  Front Biosci       Date:  2008-01-01

Review 2.  Applications of bioluminescence imaging to antiviral research and therapy: multiple luciferase enzymes and quantitation.

Authors:  Kathryn E Luker; Gary D Luker
Journal:  Antiviral Res       Date:  2008-03-05       Impact factor: 5.970

Review 3.  In vivo cell tracking with bioluminescence imaging.

Authors:  Jung Eun Kim; Senthilkumar Kalimuthu; Byeong-Cheol Ahn
Journal:  Nucl Med Mol Imaging       Date:  2014-11-26

Review 4.  Recent achievements of bioluminescence imaging based on firefly luciferin-luciferase system.

Authors:  Shufeng Li; Zhiyang Ruan; Hang Zhang; Haiwei Xu
Journal:  Eur J Med Chem       Date:  2020-12-17       Impact factor: 6.514

5.  Optical molecular imaging-guided radiation therapy part 1: Integrated x-ray and bioluminescence tomography.

Authors:  Junwei Shi; Thirupandiyur S Udayakumar; Zhiqun Wang; Nesrin Dogan; Alan Pollack; Yidong Yang
Journal:  Med Phys       Date:  2017-07-20       Impact factor: 4.071

6.  Three-dimensional reconstruction of in vivo bioluminescent sources based on multispectral imaging.

Authors:  Chaincy Kuo; Olivier Coquoz; Tamara L Troy; Heng Xu; Brad W Rice
Journal:  J Biomed Opt       Date:  2007 Mar-Apr       Impact factor: 3.170

7.  Bioluminescence: imaging modality for in vitro and in vivo gene expression.

Authors:  Ruxana T Sadikot; Timothy S Blackwell
Journal:  Methods Mol Biol       Date:  2008

8.  Luciferase imaging of a neurotropic viral infection in intact animals.

Authors:  Susan H Cook; Diane E Griffin
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 9.  Beyond D-luciferin: expanding the scope of bioluminescence imaging in vivo.

Authors:  Spencer T Adams; Stephen C Miller
Journal:  Curr Opin Chem Biol       Date:  2014-08-01       Impact factor: 8.822

Review 10.  In-vivo monitoring of infectious diseases in living animals using bioluminescence imaging.

Authors:  Pinar Avci; Mahdi Karimi; Magesh Sadasivam; Wanessa C Antunes-Melo; Elisa Carrasco; Michael R Hamblin
Journal:  Virulence       Date:  2017-12-08       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.